Longevity Acquisition Corporation Units
LOACU
LOACU was delisted on the 18th of March, 2021.
10 hedge funds and large institutions have $11.6M invested in Longevity Acquisition Corporation Units in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and closing their positions.
0% less capital invested
Capital invested by funds: $11.6M → $11.6M (-$20K)
9% less funds holding
Funds holding: 11 → 10 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$13.6K |
| 2 |
Walleye Trading
New York
|
-$3.13K |
LOACU Hedge Fund Activity: Q3 2019 in Review
10 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Longevity Acquisition Corporation Units (LOACU) for Q3 2019, worth a combined $11.6M — down 0.17% from $11.6M a quarter earlier.
Fund positioning in LOACU was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was UBS Group, cutting an estimated $13.6K.
- 10 institutional investors held Longevity Acquisition Corporation Units (LOACU) as of Q3 2019, down from 11 in Q2 2019.
- Funds reported $11.6M of Longevity Acquisition Corporation Units stock for Q3 2019, down 0.17% quarter-over-quarter.
- 0 funds opened new Longevity Acquisition Corporation Units positions in Q3 2019 and 0 closed out.
- The largest Longevity Acquisition Corporation Units seller in Q3 2019 was UBS Group, an estimated $13.6K sold.
Based on aggregated 13F filings for Q3 2019.